Inquiry Basket
| Catalog | Product Name | CAS Number |
|---|---|---|
| BADC-01944 | Boc-D-trans-Hyp-Ome | 135042-17-0 |
| Boc-D-trans-Hyp-Ome is a non-cleavable ADC linker and also an alkyl chain-based PROTAC linker. | Inquiry | |
| BADC-00889 | m-PEG8-COOH | 1093647-41-6 |
| m-PEG8-COOH is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). | Inquiry | |
| BADC-01929 | N-Boc-cis-4-Hydroxy-D-proline | 135042-12-5 |
| N-Boc-cis-4-Hydroxy-D-proline is a non-cleavable ADC linker and also an alkyl chain-based PROTAC linker. | Inquiry | |
| BADC-01147 | DSS Crosslinker | 68528-80-3 |
| DSS Crosslinker is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). | Inquiry | |
| BADC-00542 | 4-Formyl-N-(2-(2-Methoxy-4-Methylphenoxy)ethyl)benzamide | 1226006-54-7 |
| 4-Formyl-N-(2-(2-methoxy-4-methylphenoxy)ethyl)benzamide is a linker for antibody-drug-conjugation (ADC). | Inquiry | |
| BADC-00563 | N-(2-(2-Ethylphenoxy)ethyl)-4-Formylbenzamide | 1226394-63-3 |
| N-(2-(2-Ethylphenoxy)ethyl)-4-formylbenzamide is a linker for antibody-drug-conjugation (ADC). | Inquiry | |
| BADC-00618 | Mal-PEG4-VA | 1800456-31-8 |
| Mal-PEG4-VA is a noncleavable ADC linker containing a Maleimide group. Mal-PEG4-VA is used for making antibody-drug conjugate. | Inquiry | |
| BADC-00659 | Propargyl-O-C1-amido-PEG4-C2-NHS ester | 2101206-92-0 |
| Propargyl-O-C1-amido-PEG4-C2-NHS ester is a PEGn linker for antibody-drug-conjugation (ADC). | Inquiry | |
| BADC-01926 | H-D-trans-Hyp-OMe HCl | 481704-21-6 |
| H-D-trans-Hyp-OMe HCl is a non-cleavable ADC linker and also an alkyl chain-based PROTAC linker. | Inquiry | |
| BADC-01534 | BS3 Crosslinker disodium | 127634-19-9 |
| BS3 Crosslinker disodium is a well-known non-cleavable linker in antibody drug development. Furthermore, it acts as an important promoter of protein-protein interactions through complex cross-linking processes. This compound is widely used in research and diagnostics and shows great potential in exploring drug-target interactions and revealing disease mechanisms. | Inquiry | |
| BADC-00877 | Aminooxy-PEG2-azide | 1043426-13-6 |
| Aminooxy-PEG2-azide is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs. Aminooxy-PEG2-azide is also a non-cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). | Inquiry | |
| BADC-00898 | (R)-8-Azido-2-(Fmoc-amino)octanoic acid | 1191429-18-1 |
| (R)-8-Azido-2-(Fmoc-amino)octanoic acid is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). | Inquiry | |
| BADC-00901 | Azido-PEG9-amine | 1207714-69-9 |
| Azido-PEG9-amine is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs. It is also a non-cleavable 9 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). | Inquiry | |
| BADC-00902 | Azido-PEG8-propionic acid | 1214319-92-2 |
| Azido-PEG8-acid is a non-cleavable 8 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). | Inquiry | |
| BADC-00935 | Biotin-PEG2-acid | 1365655-89-5 |
| Biotin-PEG2-acid is a non-cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). | Inquiry | |
| BADC-00948 | DBCO-C6-acid | 1425485-72-8 |
| Inquiry | ||
| BADC-00967 | Propargyl-PEG5-amine | 1589522-46-2 |
| Propargyl-PEG5-amine is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Propargyl-PEG5-amine is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. | Inquiry | |
| BADC-00987 | DOTA-NHS-ester | 170908-81-3 |
| DOTA-NHS-ester is a linker for affibody molecules and is applied in small animals PET, SPECT, and CT. | Inquiry | |
| BADC-01006 | Bis-PEG1-PFP ester | 1807539-02-1 |
| Bis-PEG1-PFP ester is a non-cleavable (1 unit PEG) ADC linker used in the synthesis of antibody-drug conjugates (ADCs). | Inquiry | |
| BADC-01014 | Propargyl-PEG2-acid | 1859379-85-3 |
| Propargyl-PEG2-acid is a non-cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). | Inquiry |
